We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for Pegzilarginase (AA-Med Pty Ltd)
Active ingredients
Pegzilarginase
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
solution for injection
Indication
Treatment of hyperargininaemia
Therapeutic area
Inherited metabolic disorders